Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
CN Kohli-Lynch, J Lewsey, KA Boyd, DD French… - Circulation, 2022 - Am Heart Assoc
Background: Cholesterol guidelines typically prioritize primary prevention statin therapy on
the basis of 10-year risk of cardiovascular disease. The advent of generic pricing may justify …
the basis of 10-year risk of cardiovascular disease. The advent of generic pricing may justify …